NewAmsterdam Pharma (NAMS) Amortization of Deferred Charges (2025 - 2026)
NewAmsterdam Pharma (NAMS) reported Amortization of Deferred Charges of $10000.0 for Q1 2026, up 101.95% on a YoY basis from $4951.7 in Q1 2025, and up 141.67% sequentially from -$24000.0 in Q4 2025.
NewAmsterdam Pharma (NAMS) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends
NewAmsterdam Pharma (NAMS) has 2 years of Amortization of Deferred Charges data on file, last reported at $10000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges rose 101.95% year-over-year to $10000.0; the trailing twelve-month figure through Mar 2026 stood at -$882000.0 (changed N/A YoY), and the FY2025 full-year result was -$1.4 million, down 518.94% from the prior year.
- Amortization of Deferred Charges climbed to $10000.0 in Q1 2026, from -$24000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $10000.0 in Q1 2026 to a low of -$513000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - |
| 10 | NewAmsterdam Pharma | 3.69 Bn | 3.69 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Sep 30, 2025 | -396,000.00 |
| Sep 30, 2025 | -396,000.00 |
| Jun 30, 2025 | -472,000.00 |
| Jun 30, 2025 | -472,000.00 |
| Mar 31, 2025 | -513,000.00 |
| Mar 31, 2025 | -513,000.00 |